Using low-dose aspirin to improve heart health after pregnancy complications
Official title: Postpartum low-dose aspirin to augment vascular recovery following a hypertensive disorder of pregnancy
Funded at Women and Infants Hospital-Rhode Island · NIH-11179697 · Data updated 2026-11-12
This study is looking at whether taking low-dose aspirin can help improve heart and blood vessel health in women who have had preeclampsia after giving birth, and it’s for those who want to know if this could be a helpful option for their recovery.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Women and Infants Hospital-Rhode Island NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project start | August 1, 2024 |
| Project end | July 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $167,722 |
| NIH project number | 7K23HL168356-02 |
| Project ID | NIH-11179697 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women who have recently experienced preeclampsia and are in the immediate postpartum period.
✕Less likely to help
Patients who have not experienced preeclampsia or those who are not in the postpartum period may not benefit from this research.
What this research studies
This research investigates the use of low-dose aspirin to enhance vascular recovery in women who have experienced preeclampsia, a condition that can lead to high blood pressure and increased cardiovascular disease risk postpartum. The study will conduct a pilot trial to evaluate the feasibility of administering low-dose aspirin compared to a placebo in the immediate postpartum period. Participants will be monitored for changes in endothelial function and blood pressure over six months, aiming to establish a new approach to postpartum care for women at risk of cardiovascular issues.
Why it matters
Potential benefit: If successful, this research could lead to improved heart health and reduced cardiovascular disease risk for women who have had preeclampsia.
How similar studies have gone: While the approach of using low-dose aspirin postpartum is emerging, there is limited evidence on its effectiveness specifically for women with a history of preeclampsia, making this research a novel exploration.
Where this research is happening
-
Women and Infants Hospital-Rhode Island
Providence, United States Active
Researchers
- Principal investigator: Hauspurg, Alisse — Women and Infants Hospital-Rhode Island
- Study coordinator: Hauspurg, Alisse
Related research
Other NIH-funded projects on the same topics.
-
Low-dose aspirin after pregnancy high blood pressure to help blood vessels heal
People who had preeclampsia will take low-dose aspirin or a placebo after delivery to help blood vessels recover and lower blood pressure within six months.
-
CREBRF gene and diabetes risk in American Samoan pregnancies
This project follows 350 pregnant American Samoan women to understand how a specific gene variant may influence diabetes risk during and after pregnancy.
-
Healthy Families-PrEP: helping women in Uganda start and stay on PrEP during periconception, pregnancy, and postpartum
A program in Uganda helps periconception, pregnant, and postpartum women use PrEP safely to prevent HIV, with support sessions and monitoring.
-
Healthy Families-PrEP: helping pregnant and new mothers in Uganda stay HIV-free
A family-focused program in Uganda tests an approach to help women who are planning pregnancy or are pregnant or postpartum use PrEP to prevent HIV infection.
-
LA-MOM: Long-Acting HIV ART in Pregnancy and After Birth
This study follows pregnant people with HIV who receive long-acting injectable HIV medicines to understand how the drugs behave in the body, how they reach the baby, and what patients experience during pregnancy and after birth.
-
Effects of prescription opioid use during pregnancy on a mother's brain after birth
This project looks at how taking prescription opioids during pregnancy changes a mother's brain and behavior after her baby is born.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.